The Leukemia & Lymphoma Society’s Therapy Acceleration Program
North America, New York, United States, New York
Description
LLS provised, strategic venture philanthropy initiative that seeks to accelerate the development of innovative blood cancer therapeutics.
Investor Profile
The Leukemia & Lymphoma Society’s Therapy Acceleration Program has made 3 investments, with 0 in the past 12 months and 33% as lead.
Stage Focus
- Series Unknown (67%)
- Series A (33%)
Country Focus
- United States (67%)
- France (33%)
Industry Focus
- Biotechnology
- Health Care
- Bioinformatics
- Test And Measurement
- Biopharma
- Life Science
- Medical
- Oncology
- Pharmaceutical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
